Stryker Corporation (SYK)
NYSE: SYK · IEX Real-Time Price · USD
+0.75 (0.22%)
At close: Jul 11, 2024, 4:00 PM
+1.76 (0.52%)
Pre-market: Jul 12, 2024, 4:03 AM EDT

Stryker Revenue

Stryker had revenue of $20.96B in the twelve months ending March 31, 2024, with 10.61% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $5.24B with 9.73% year-over-year growth. In the year 2023, Stryker had annual revenue of $20.50B with 11.11% growth.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
128.80B USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 202320.50B2.05B11.11%
Dec 31, 202218.45B1.34B7.84%
Dec 31, 202117.11B2.76B19.21%
Dec 31, 202014.35B-533.00M-3.58%
Dec 31, 201914.88B1.28B9.43%
Dec 31, 201813.60B1.16B9.30%
Dec 31, 201712.44B1.12B9.88%
Dec 31, 201611.33B1.38B13.86%
Dec 31, 20159.95B271.00M2.80%
Dec 31, 20149.68B654.00M7.25%
Dec 31, 20139.02B364.00M4.20%
Dec 31, 20128.66B350.00M4.21%
Dec 31, 20118.31B987.00M13.48%
Dec 31, 20107.32B597.00M8.88%
Dec 31, 20096.72B4.80M0.07%
Dec 31, 20086.72B717.70M11.96%
Dec 31, 20076.00B853.30M16.58%
Dec 31, 20065.15B538.30M11.68%
Dec 31, 20054.61B346.60M8.13%
Dec 31, 20044.26B637.00M17.57%
Dec 31, 20033.63B613.70M20.38%
Dec 31, 20023.01B409.30M15.73%
Dec 31, 20012.60B312.90M13.67%
Dec 31, 20002.29B185.70M8.83%
Dec 31, 19992.10B1.00B90.69%
Dec 31, 19981.10B123.10M12.56%
Dec 31, 1997980.10M70.04M7.70%
Dec 31, 1996910.06M38.11M4.37%
Dec 31, 1995871.95M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Elevance Health 171.75B
Pfizer 55.09B
Sanofi 51.60B
Abbott Laboratories 40.33B
Amgen 29.53B
Danaher 22.52B
Boston Scientific 14.71B
Regeneron Pharmaceuticals 13.10B
Revenue Rankings